Options: Show MedDRA Preferred Terms
| Side effect | Data for drug | Placebo | Labels | |
|---|---|---|---|---|
| 1 | 2 | |||
| Nausea | postmarketing, 3.1% - 7.5% | x | x | |
| Oedema peripheral | 2% - 3.2% | x | ||
| Headache | postmarketing, 1.8% - 2.1% | x | x | |
| Vomiting | postmarketing, 1.5% - 5% | x | x | |
| Oedema | 1.4% - 1.5% | x | ||
| Abdominal pain | postmarketing, 1.3% - 1.4% | x | x | |
| Cough | postmarketing, 1.3% - 1.4% | x | x | |
| Constipation | postmarketing, 2.1% | x | x | |
| Dyspnoea | postmarketing, 1% - 1.1% | x | x | |
| Muscle spasms | postmarketing, 1% - 1.4% | x | x | |
| Dizziness | postmarketing, 1.8% - 2.6% | x | x | |
| Body temperature increased | postmarketing, 0.7% - 1% | x | x | |
| Hypertension | postmarketing, 1% | x | x | |
| Chest pain | postmarketing, 0.7% - 1.3% | x | x | |
| Rash | postmarketing, 0.4% - 1% | x | x | |
| Pruritus | postmarketing, 0.4% - 1.2% | x | x | |
| Abdominal distension | postmarketing | x | ||
| Anaphylactic shock | postmarketing | x | ||
| Angioedema | postmarketing | x | x | |
| Arrhythmia | postmarketing | x | ||
| Arthralgia | postmarketing | x | ||
| Asthenia | postmarketing | x | ||
| Back pain | postmarketing, 0% - 1% | x | x | |
| Bronchospasm | postmarketing | x | ||
| Contusion | postmarketing | x | ||
| Cyanosis | postmarketing | x | x | |
| Dehydration | postmarketing | x | ||
| Diarrhoea | postmarketing, 4% | x | x | |
| Dysgeusia | postmarketing | x | ||
| Dyspepsia | postmarketing | x | ||
| Ecchymosis | postmarketing | x | x | |
| Eosinophilia | postmarketing | x | ||
| Epistaxis | postmarketing | x | ||
| Eye disorder | postmarketing | x | ||
| Fatigue | postmarketing | x | ||
| Flushing | postmarketing | x | ||
| Gastrointestinal disorder | postmarketing | x | ||
| Glossodynia | postmarketing | x | ||
| Gout | postmarketing | x | ||
| Cardiac arrest | postmarketing | x | ||
| Cardiac failure congestive | postmarketing | x | x | |
| Haemorrhage | postmarketing | x | ||
| Hyperhidrosis | postmarketing | x | ||
| Hyperkalaemia | postmarketing | x | ||
| Hypersensitivity | postmarketing | x | x | |
| Malignant hypertension | postmarketing | x | ||
| Hyperventilation | postmarketing | x | ||
| Hypotension | postmarketing, 0.4% - 2.5% | x | x | |
| Immune system disorder | postmarketing | x | ||
| Renal failure chronic | postmarketing | x | x | |
| Laryngeal oedema | postmarketing | x | ||
| Mediastinal disorder | postmarketing | x | ||
| Myocardial infarction | postmarketing | x | ||
| Nervous system disorder | postmarketing | x | ||
| Night sweats | postmarketing | x | ||
| Pain | postmarketing | x | ||
| Paraesthesia | postmarketing | x | ||
| Prurigo | postmarketing | x | ||
| Sweating | postmarketing | x | ||
| Swelling | postmarketing | x | ||
| Syncope | postmarketing | x | x | |
| Tachycardia | postmarketing | x | x | |
| Loss of consciousness | postmarketing | x | x | |
| Urticaria | postmarketing | x | x | |
| Angiopathy | postmarketing | x | ||
| Vasodilation | postmarketing | x | ||
| Wheezing | postmarketing | x | ||
| Dry mouth | postmarketing | x | ||
| Fever chills | postmarketing | x | ||
| Burning sensation | postmarketing | x | ||
| Hepatic function abnormal | postmarketing | x | ||
| Injection site reaction | postmarketing | x | ||
| Muscular weakness | postmarketing | x | ||
| Lacrimation increased | postmarketing | x | ||
| Respiratory arrest | postmarketing | x | ||
| Malnutrition | postmarketing | x | ||
| Skin hyperpigmentation | postmarketing | x | ||
| Myalgia | postmarketing | x | ||
| Increased appetite | postmarketing | x | ||
| Decreased appetite | postmarketing | x | ||
| Abdominal discomfort | postmarketing | x | ||
| Abdominal pain upper | postmarketing | x | ||
| Faeces discoloured | postmarketing | x | ||
| Chest discomfort | postmarketing | x | ||
| Pharyngeal oedema | postmarketing | x | ||
| Swollen tongue | postmarketing | x | ||
| Throat tightness | postmarketing | x | ||
| Lip swelling | postmarketing | x | ||
| Serum ferritin increased | postmarketing | x | x | |
| Hypoxia | postmarketing | x | ||
| Hepatobiliary disease | postmarketing | x | ||
| Pulse absent | postmarketing | x | x | |
| Anaphylactoid reaction | postmarketing | x | ||
| Vision blurred | postmarketing | x | ||
| Warmth | postmarketing | x | ||
| Stiffness | postmarketing | x | ||
| Pruritus generalised | postmarketing | x | ||
| Rash generalised | postmarketing | x | ||
| Injection site bruising | postmarketing | x | ||
| Blood glucose decreased | postmarketing | x | ||
| Hot flush | postmarketing | x | ||
| Cardio-respiratory arrest | postmarketing | x | x | |
| Throat irritation | postmarketing | x | ||
| Oxygen saturation decreased | postmarketing | x | ||
| Blood and lymphatic system disorders | postmarketing | x | ||
| Injection site pruritus | postmarketing | x | ||
| Musculoskeletal stiffness | postmarketing | x | ||
| Injection site discolouration | postmarketing | x | ||
| Infusion site swelling | postmarketing | x | x | |
| Respiratory failure | postmarketing | x | ||
| Somnolence | postmarketing | x | ||
| Feeling hot | postmarketing | x | ||
| Gastrointestinal symptom NOS | x | |||
| Hypotensive | x | |||
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |